RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects

Abstract excerpt

Heterozygous defects in runt-related transcription factor 1 (RUNX1) are causative of a familial platelet disorder with associated myeloid malignancy (FPDMM). Because RUNX1-deficient animal models do not mimic bleeding disorder or leukemic risk associated with FPDMM, development of a proper model system is critical to understanding the underlying mechanisms of the observed phenotype and to identifying therapeutic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antiplatelet Therapy and Cardiovascular Diseases
• Share to Myeloproliferative Neoplasms: Diagnosis and Treatment
• Share to Platelet Disorders and Treatments